ARCHIVES

Analysis Reveals Patient Subset With Lower PFS in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 34 No. 12 | December 30, 2011

Download PDF Visit The Full Archive

Related Articles

NCI Raises R01 Payline To 16th Percentile FY09. Coalition Formed To Advocate For Medical Innovation

March 27, 2009

Greenberg Named UT System Vice Chancellor For Health Affairs

July 19, 2013

Vaccine Increases PFS 146%, OS 60% In Phase II Clinical Trial

May 31, 2013

NCI Plans For Research In Breast, Prostate Cancer, Drafted

January 28, 1994

In Brief: NCI To Supply Maytansine For Several Phase I Studies; Holleb Urges Referrals To “Experts”

March 26, 1976

Research Dollars Save Money, Lives, Scientists Tell Senate

May 3, 1991